These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27589992)

  • 1. Insulin resistance, glucagon-like peptide-1 and factors influencing glucose homeostasis in neonates.
    Salis ER; Reith DM; Wheeler BJ; Broadbent RS; Medlicott NJ
    Arch Dis Child Fetal Neonatal Ed; 2017 Mar; 102(2):F162-F166. PubMed ID: 27589992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycaemic preterm neonates exhibit insulin resistance and low insulin production.
    Salis ER; Reith DM; Wheeler BJ; Broadbent RS; Medlicott NJ
    BMJ Paediatr Open; 2017; 1(1):e000160. PubMed ID: 29637163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period.
    Padidela R; Patterson M; Sharief N; Ghatei M; Hussain K
    Eur J Endocrinol; 2009 Jan; 160(1):53-8. PubMed ID: 18952761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans.
    Wu T; Bound MJ; Standfield SD; Jones KL; Horowitz M; Rayner CK
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E718-22. PubMed ID: 23418316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance prior to term age in very low birthweight infants: a prospective study.
    Zamir I; Stoltz Sjöström E; van den Berg J; Naumburg E; Domellöf M
    BMJ Paediatr Open; 2024 Feb; 8(1):. PubMed ID: 38341196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin and islet hormone responses to meals of increasing size in healthy subjects.
    Alsalim W; Omar B; Pacini G; Bizzotto R; Mari A; Ahrén B
    J Clin Endocrinol Metab; 2015 Feb; 100(2):561-8. PubMed ID: 25375983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations and effects of glucagon-like peptide-1 (7-36) amide in calves before and after weaning.
    Fukumori R; Mita T; Sugino T; Obitsu T; Taniguchi K
    Domest Anim Endocrinol; 2012 Nov; 43(4):299-306. PubMed ID: 22683323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
    Egan JM; Meneilly GS; Habener JF; Elahi D
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3768-73. PubMed ID: 12161508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
    Jiménez A; Casamitjana R; Flores L; Delgado S; Lacy A; Vidal J
    Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
    Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.
    D'Alessio DA; Kahn SE; Leusner CR; Ensinck JW
    J Clin Invest; 1994 May; 93(5):2263-6. PubMed ID: 8182159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inadequate glycaemic response to glucagon is linked to insulin resistance in preterm infants?
    Jackson L; Burchell A; McGeechan A; Hume R
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F62-6. PubMed ID: 12496230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA; Siemsglüss J; Orskov C; Holst JJ
    Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting glucagon-like peptide-1 and its relation to insulin in obese children before and after weight loss.
    Reinehr T; de Sousa G; Roth CL
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):608-12. PubMed ID: 17460495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
    Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
    Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
    Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.
    Zander M; Madsbad S; Madsen JL; Holst JJ
    Lancet; 2002 Mar; 359(9309):824-30. PubMed ID: 11897280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.